Postnatal Germ Cell Development in the Cryptorchid Testis: The Key to Explain Why Early Surgery Decreases the Risk of Malignancy
12 May 2017
04 July 2017
24 August 2017 (eFirst)
Purpose Cryptorchidism is a risk factor for testicular malignancy and surgical treatment lowers this risk. This study aimed to investigate the germ cell behavior in prepubertal cryptorchid testes using immunohistochemical markers for germ cell malignancy to understand how early orchiopexy may possibly prevent cancer developing.
Materials and Methods Histology sections from 1,521 consecutive testicular biopsies from 1,134 boys aged 1 month to 16.5 years operated for cryptorchidism were incubated with antibodies including antiplacental-like alkaline phosphatase (PLAP), anti-Oct3/4, anti-C-kit, and anti-D2–40.
Results Oct3/4 and D2–40-positive germ cells are found throughout the first 2 years of life, with declining frequency thereafter. After 2 years, they should have disappeared and may indicate neoplasia. PLAP-positive cells were seen in 57 to 82% and C-kit-positive cells in 5 to 21% of cryptorchid testes between 4 and 13 years. Not until puberty did PLAP and C-kit-positive undifferentiated spermatogonial stem cells vanish. Only 0.3% of the present material had obvious prepubertal intratubular germ cell neoplasia (ITGCN) and they all had syndromic cryptorchidism. An additional three boys (0.3%) older than 2 years had weak Oct3/4 expression in undescended testes, but all cases were D2–40 negative.
Conclusion Prepubertal ITGCN was rare and mostly seen in syndromic cryptorchidism. In nonsyndromic cryptorchidism PLAP-positive undifferentiated spermatogonial stem cells persisted in a significant proportion of nontreated undescended testes and they will be especially sensitive to long-lasting abnormally high temperature that may be the single most important cause facilitating the accumulation of mutations during cell replication and the development of ITGCN to be prevented by orchiopexy.
Keywordscryptorchidism - testicular cancer - intratubular germ cell neoplasia - immunohistochemistry - germ cells
This study was conducted according to the Helsinki II declaration, and informed consent was obtained from the parents of the patients. This study was approved by Ethics Committee of Copenhagen, original file number KF-01299830.
- 1 Thorup J, McLachlan R, Cortes D. , et al. What is new in cryptorchidism and hypospadias--a critical review on the testicular dysgenesis hypothesis. J Pediatr Surg 2010; 45 (10) 2074-2086
- 2 Hanna NH, Einhorn LH. Testicular cancer--discoveries and updates. N Engl J Med 2014; 371 (21) 2005-2016
- 3 Moller H. Epidemiological Studies of Testicular Germ Cell Cancer. London: Thames Cancer Registry, Kings College; 2001
- 4 Pettersson A, Richiardi L, Nordenskjold A, Kaijser M, Akre O. Age at surgery for undescended testis and risk of testicular cancer. N Engl J Med 2007; 356 (18) 1835-1841
- 5 Osterballe L, Clasen-Linde E, Cortes D. , et al. The diagnostic impact of testicular biopsies for intratubular germ cell neoplasia in cryptorchid boys and the subsequent risk of testicular cancer in men with prepubertal surgery for syndromic or non-syndromic cryptorchidism. J Pediatr Surg 2017; 52 (04) 587-592
- 6 Walsh TJ, Dall'Era MA, Croughan MS, Carroll PR, Turek PJ. Prepubertal orchiopexy for cryptorchidism may be associated with lower risk of testicular cancer. J Urol 2007; 178 (4 Pt 1): 1440-1446 , discussion 1446
- 7 Skakkebaek NE, Rajpert-De Meyts E, Buck Louis GM. , et al. Male reproductive disorders and fertility trends: influences of environment and genetic susceptibility. Physiol Rev 2016; 96 (01) 55-97
- 8 Skakkebaek NE, Berthelsen JG, Giwercman A, Müller J. Carcinoma-in-situ of the testis: possible origin from gonocytes and precursor of all types of germ cell tumours except spermatocytoma. Int J Androl 1987; 10 (01) 19-28
- 9 Cortes D. Cryptorchidism--aspects of pathogenesis, histology and treatment. Scand J Urol Nephrol Suppl 1998; 196: 1-54
- 10 Hornák M, Pauer M, Bárdos Jr A, Ondrus D. The incidence of carcinoma in situ in postpubertal undescended testis. Int Urol Nephrol 1987; 19 (03) 321-325
- 11 Koni A, Ozseker HS, Arpali E. , et al. Histopathological evaluation of orchiectomy specimens in 51 late postpubertal men with unilateral cryptorchidism. J Urol 2014; 192 (04) 1183-1188
- 12 Soltanghoraee H, Pourkeramati F, Khoddami M, Amirjannati N, Akhondi MM, Soltani A. Prevalence of carcinoma in situ in testicular biopsies of infertile Iranian men. Andrologia 2014; 46 (07) 726-730
- 13 Krabbe S, Skakkebaek NE, Berthelsen JG. , et al. High incidence of undetected neoplasia in maldescended testes. Lancet 1979; 1 (8124): 999-1000
- 14 Giwercman A, Bruun E, Frimodt-Møller C, Skakkebaek NE. Prevalence of carcinoma in situ and other histopathological abnormalities in testes of men with a history of cryptorchidism. J Urol 1989; 142 (04) 998-1001
- 15 Hutson JM, Li R, Southwell BR, Petersen BL, Thorup J, Cortes D. Germ cell development in the postnatal testis: the key to prevent malignancy in cryptorchidism?. Front Endocrinol (Lausanne) 2013; 3: 176
- 16 Kvist K, Clasen-Linde E, Cortes D, Petersen BL, Thorup J. Adult immunohistochemical markers fail to detect intratubular germ cell neoplasia in prepubertal boys with cryptorchidism. J Urol 2014; 191 (04) 1084-1089
- 17 Clasen-Linde E, Kvist K, Cortes D, Thorup J. The value of positive Oct3/4 and D2-40 immunohistochemical expression in prediction of germ cell neoplasia in prepubertal boys with cryptorchidism. Scand J Urol 2016; 50 (01) 74-79
- 18 Cortes D. Histological versus stereological methods applied at spermatogonia during normal human development. Scand J Urol Nephrol 1990; 24 (01) 11-15
- 19 Li R, Thorup J, Sun C, Cortes D, Southwell B, Hutson J. Immunofluorescent analysis of testicular biopsies with germ cell and Sertoli cell markers shows significant MVH negative germ cell depletion with older age at orchiopexy. J Urol 2014; 191 (02) 458-464
- 20 Looijenga LHJ, Stoop H, de Leeuw HPJ. , et al. POU5F1 (OCT3/4) identifies cells with pluripotent potential in human germ cell tumors. Cancer Res 2003; 63 (09) 2244-2250
- 21 Honecker F, Stoop H, de Krijger RR, Chris Lau YF, Bokemeyer C, Looijenga LH. Pathobiological implications of the expression of markers of testicular carcinoma in situ by fetal germ cells. J Pathol 2004; 203 (03) 849-857
- 22 Hadziselimovic F, Emmons LR, Buser MW. A diminished postnatal surge of Ad spermatogonia in cryptorchid infants is additional evidence for hypogonadotropic hypogonadism. Swiss Med Wkly 2004; 134 (25-26): 381-384
- 23 Sonne SB, Herlihy AS, Hoei-Hansen CE. , et al. Identity of M2A (D2-40) antigen and gp36 (Aggrus, T1A-2, podoplanin) in human developing testis, testicular carcinoma in situ and germ-cell tumours. Virchows Arch 2006; 449 (02) 200-206
- 24 Kvist K, Clasen-Linde E, Langballe O. , et al. Immunohistochemical expression of markers for IntraTubular Germ Cell Neoplasia in normal infantile testes. Available at: https://www.espu.org/members/previous-events-abstracts/261-2016-programme-and-abstracts-harrogate-uk . Accessed July 27, 2017
- 25 Drumond AL, Meistrich ML, Chiarini-Garcia H. Spermatogonial morphology and kinetics during testis development in mice: a high-resolution light microscopy approach. Reproduction 2011; 142 (01) 145-155
- 26 Huff DS, Snyder III HM, Rusnack SL, Zderic SA, Carr MC, Canning DA. Hormonal therapy for the subfertility of cryptorchidism. Horm Res 2001; 55 (01) 38-40
- 27 Li R, Vannitamby A, Zhang JG, Fehmel EL, Southwell BR, Hutson JM. Oct4-GFP expression during transformation of gonocytes into spermatogonial stem cells in the perinatal mouse testis. J Pediatr Surg 2015; 50 (12) 2084-2089
- 28 Biermann K, Stoop H, Looijenga L. c-KIT protein expression does not discriminate neoplastic from non-neoplastic intratubular germ cells. Histopathology 2012; 60 (06) 1017-1019
- 29 Thorup J, Clasen-Linde E, Cortes D. Positive Oct -3/4 and D2-40 immunohistochemical expression in germ cells and suspected histology pattern of intratubular germ cell neoplasia in boys with cryptorchidism vanish after the age of 2 years. Eur J Pediatr Surg 2017; 27 (04) 313-318
- 30 Jørgensen N, Rajpert-De Meyts E, Graem N, Müller J, Giwercman A, Skakkebaek NE. Expression of immunohistochemical markers for testicular carcinoma in situ by normal human fetal germ cells. Lab Invest 1995; 72 (02) 223-231
- 31 McCann-Crosby B, Gunn S, Smith EO, Karaviti L, Hicks MJ. Association of immunohistochemical markers with premalignancy in gonadal dysgenesis. Int J Pediatr Endocrinol 2015; 2015 (01) 14